Please use this identifier to cite or link to this item:
http://hdl.handle.net/11054/1996
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Mangira, D. | en_US |
dc.contributor | Raftopoulos, S. | en_US |
dc.contributor | Hartley, I. | en_US |
dc.contributor | Mack, A. | en_US |
dc.contributor | Gazelakis, K. | en_US |
dc.contributor | Nalankilli, K. | en_US |
dc.contributor | Elliott, Timothy R. | en_US |
dc.contributor | Moss, A. | en_US |
dc.date.accessioned | 2022-11-14T23:07:30Z | - |
dc.date.available | 2022-11-14T23:07:30Z | - |
dc.date.issued | 2022 | - |
dc.identifier.govdoc | 01950 | en_US |
dc.identifier.uri | http://hdl.handle.net/11054/1996 | - |
dc.description.abstract | Aims: CSP is the standard of care for resecting small (<10mm) colonic polyps. However, limited data exists for its efficacy for medium-sized (10-19mm) sessile polyps. This study evaluated the efficacy and safety of CSP/C-EMR for medium-sized sessile colonic polyps. Methods: An Australian prospective multicentre study was conducted between May-2018 and June-2021, including all consecutive cases of CSP/C-EMR for 10-19mm sessile colonic polyps. Once resection was deemed complete, the margins of resection sites were biopsied circumferentially and centrally. Primary outcome: presence of residual polyp in these biopsy specimens. Secondary outcomes: recurrence rate at first surveillance colonoscopy and rates of adverse events. Results: CSP/C-EMR was performed for 350 polyps in 295 patients. Median polyp size: 15mm. Submucosal injection to lift polyps was used in 87.1% (n=305) of polyps. Histology: 68.5% adenomas, 26.2% SSA/P without dysplasia, 3.8% SSA/P with dysplasia and 1.4% hyperplastic polyps. Primary outcome: Margin and central biopsies were positive in 1.7%(n=6) and 0.3%(n=1) of polyps respectively. Secondary outcomes: Polyp recurrence was present in 1.7%(n=4) of cases at first surveillance colonoscopy that had been completed for 64.2%(n=225) of polyps at a median interval of 9.7 months. Adverse events occurred in 3.4%(n=10) of patients: 1 had intraprocedural bleeding (clipped), 3 had self-limiting post-polypectomy bleeding, 4 had post-polypectomy pain and 2 had post-polypectomy syndrome. There were no perforations. Conclusions: CSP/C-EMR for 10-19mm sessile colonic polyps is highly effective and safe. Rates of incomplete resection and recurrence at surveillance were low, with few adverse events. | en_US |
dc.description.provenance | Submitted by Gemma Siemensma (gemmas@bhs.org.au) on 2022-11-10T00:14:30Z No. of bitstreams: 0 | en |
dc.description.provenance | Approved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2022-11-14T23:07:30Z (GMT) No. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2022-11-14T23:07:30Z (GMT). No. of bitstreams: 0 Previous issue date: 2022 | en |
dc.title | Cold snare polypectomy (CSP)/Cold EMR (C-EMR) for medium-sized (10-19mm) sessile colonic polyps: A prospective multicentre study. | en_US |
dc.type | Conference | en_US |
dc.type.specified | Paper | en_US |
dc.bibliographicCitation.conferencedate | April 28-30 | en_US |
dc.bibliographicCitation.conferencename | ESGE Days 2022 | en_US |
dc.bibliographicCitation.conferenceplace | Prague | en_US |
dc.subject.healththesaurus | COLONIC POLYPS | en_US |
dc.subject.healththesaurus | COLD SNARE POLYPECTOMY | en_US |
Appears in Collections: | Research Output |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.